维普中文期刊产品整合服务
1007篇 您的检索式:期刊名="Immunotherapy"
    题名 作者 年代 出处 被引量
1Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells显示文摘G. Stuber F. Vánky E. Pócsik M. Benczúr E. Klein 1990Cancer Immunology Immunotherapy1990,,2:4
2Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis显示文摘Michael R. Verneris Martin Kornacker Volker Mail?nder Robert S. Negrin 2000Cancer Immunology, Immunotherapy2000,,6:3
3?509C>T polymorphism in the TGF-β1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection显示文摘Peng Qi Yue-ming Chen Hao Wang Meng Fang Qiang Ji Yun-peng Zhao Xiao-juan Sun Yan Liu Chun-fang Gao 2009Cancer Immunology, Immunotherapy2009,,:3
4Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma显示文摘Roniel Cabrera Miguel Ararat Yiling Xu Todd Brusko Clive Wasserfall Mark A. Atkinson Lung Ji Chang Chen Liu David R. Nelson 2013Cancer Immunology Immunotherapy2013,,4:3
5Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo显示文摘Cor H. J. Lamers Sabine C. L. Langeveld Corrien M. Groot-van Ruijven Reno Debets Stefan Sleijfer Jan Willem Gratama Cancer Immunology Immunotherapy0,,:2
6Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients显示文摘Lili Yang Baozhu Ren Hui Li Jinpu Yu Shui Cao Xishan Hao Xiubao Ren 2013Cancer Immunology Immunotherapy2013,,1:2
7Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study显示文摘Runmei Li Changli Wang Liang Liu Chunjuan Du Shui Cao Jinpu Yu Shizhen Emily Wang Xishan Hao Xiubao Ren Hui Li 2012Cancer Immunology Immunotherapy2012,,11:2
8Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival显示文摘Richard W. Griffiths Eyad Elkord David E. Gilham Vijay Ramani Noel Clarke Peter L. Stern Robert E. Hawkins 2007Cancer Immunology, Immunotherapy2007,,:2
9Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10显示文摘Mingzhong Zheng Dora Bocangel Blair Doneske Abner Mhashilkar Rajagopal Ramesh Kelly K. Hunt Suhendan Ekmekcioglu R. Bryan Sutton Nancy Poindexter Elizabeth A. Grimm Sunil Chada 2007Cancer Immunology Immunotherapy2007,,2:2
10Immunotherapy synergizes with chemotherapy targeting pancreatic cancer显示文摘Shigeo Koido Sadamu Homma Akitaka Takahara Yoshihisa Namiki Hideo Komita Kan Uchiyama Masaki Ito Jianlin Gong Toshifumi Ohkusa Hisao Tajiri 2012Immunotherapy2012,,1:2
11Role of proliferation in LAK cell development显示文摘Frederick J. Ramsdell Hungyi Shau Sidney H. Golub 1988Cancer Immunology Immunotherapy1988,,2:2
12Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis显示文摘Masanori Kobayashi Shigetaka Shimodaira Kazuhiro Nagai Masahiro Ogasawara Hidenori Takahashi Hirofumi Abe Mitsugu Tanii Masato Okamoto Sun-ichi Tsujitani Seiichi Yusa Takefumi Ishidao Junji Kishimoto Yuta Shibamoto Masaki Nagaya Yoshikazu Yonemitsu 2014Cancer Immunology, Immunotherapy2014,,:2
13Combination strategies to enhance antitumor ADCC显示文摘Holbrook E Kohrt Roch Houot Auré lien Marabelle Hearn Jay Cho Keren Osman Matthew Goldstein Ronald Levy Joshua Brody 2012Immunotherapy2012,,5:2
14Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell–leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination显示文摘Joanna Galea-Lauri David Darling Ghulam Mufti Phillip Harrison Farzin Farzaneh 2002Cancer Immunology, Immunotherapy2002,,6:2
15Clinical applications of dendritic cell vaccination in the treatment of cancer显示文摘Lee D. Cranmer Katrina T. Trevor Evan M. Hersh 2004Cancer Immunology, Immunotherapy2004,,4:2
16HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response显示文摘Gaia Codolo Matteo Fassan Fabio Munari Andrea Volpe Piefrancesco Bassi Massimo Rugge Francesco Pagano Mario Milco D’Elios Marina Bernard 2012Cancer Immunology Immunotherapy2012,,1:2
17Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?显示文摘Nathalie Cools Annacarmen Petrizzo Evelien Smits Franco M Buonaguro Maria L Tornesello Zwi Berneman Luigi Buonaguro 2011Immunotherapy2011,,10:2
18Circulating tumor cells as therapy-related biomarkers in cancer patients显示文摘Tobias M. Gorges Klaus Pantel 2013Cancer Immunology, Immunotherapy2013,,5:2
19Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen显示文摘Tsuyoshi Itoh Yuji Ueda Ichiro Kawashima Ikuei Nukaya Hitoshi Fujiwara Nobuaki Fuji Tetsuro Yamashita Tetsunori Yoshimura Kaori Okugawa Tomoko Iwasaki Mitsuko Ideno Kazutoh Takesako Masakazu Mitsuhashi Kunzo Orita Hisakazu Yamagishi 2002Cancer Immunology,Immunotherapy2002,,2:2
20Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions显示文摘Amedeo Amedei Elena Niccolai Marisa Benagiano Chiara Della Bella Fabio Cianchi Paolo Bechi Antonio Taddei Lapo Bencini Marco Farsi Paola Cappello Domenico Prisco Francesco Novelli Mario Milco D’Elios 2013Cancer Immunology, Immunotherapy2013,,7:2
返回顶部 每页显示:
共51页 首页 上一页 第1页 下一页 末页 /51 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费